Axithra

Genk, Belgium

Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.

$10.7M raised

Sep 2023

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Axithra raised?

Axithra has raised $10.7M in total funding. The most recent round was Seed. The last funding was announced in September 2023.

Who are Axithra's investors?

Axithra's investors include imec.xpand, Kurma Partners, White Fund, Werfen, Hamamatsu Photonics.

Where is Axithra headquartered?

Axithra is headquartered in Genk, Belgium.

What does Axithra do?

Axithra provides therapeutic medication monitoring and measures beta-lactam antibiotic concentrations in blood.

What stage is Axithra at?

Axithra is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 5, 2023.

MLA

"Axithra — Funding & Investors." VCBacked, September 5, 2023, https://www.vcbacked.co/company/axithra. Accessed July 3, 2026.

APA

VCBacked. (2023). Axithra — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/axithra

Wikipedia (cite web)

{{cite web |title=Axithra — Funding & Investors |url=https://www.vcbacked.co/company/axithra |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 5, 2023.